Sponsored by:

Complimentary Virtual Event

April 2, 2019
12:00 Noon - 4:00 PM EDT

Complimentary Webinar

2nd Annual Cannabis Labs Virtual Conference

Register Now!

CannabisIndustryJournal.com is proud to present the 2nd Annual Cannabis Labs Virtual Conference. This complimentary collection of webinar presentations will help attendees better understand some of the more technical aspects of starting and operating a laboratory. We will take a deep dive into pesticide testing, cannabinoid and terpene testing, the new ISO 17025:2017 accreditation and a lesson in starting a laboratory in a new market.

Attendees registering for this complimentary series of webinars will get access to four veterans of the cannabis lab testing industry, who are available for Q&A after each presentation. In addition to getting the opportunity to chat with these subject matter experts on April 2nd, a recording of the presentations will be made available to all who register.

Practical and educational information from experts in the cannabis lab testing industry, all on the same day and all from the comfort of your office, lab or home. Want real inside knowledge on the cannabis testing industry? Sign up today!

Who Should Attend:

  • Cannabis Laboratory personnel, Lab managers, Chemists, Microbiologists, Investors of Cannabis Labs, those looking to start a lab, clients of laboratories including: growers, processors, dispensary managers and stakeholders in  the cannabis lab testing market.

Agenda

12:00 PM - Welcome & Introductions
Aaron Biros, Editor, Cannabis Industry Journal - Host and Moderator

12:05 PM - Pesticide Testing: Methods, Strategies & Sampling
Charles Deibel, President & CEO - Deibel Labs, Inc.

Pesticides represent the number one area for Batch Failures in the US Cannabis market. These are concerns not only for consumers, but are a very big concern for cultivators and manufacturers of cannabis products. remediation of the pesticides, once they are in the product are not always feasible From the Lab level, they are also the hardest test to run in the laboratory, even one equipped with state-of-the-art equipment. The best instruments on the market are very expensive and there are no standardized methods, meaning lab to lab variability has happened.

  • What are the Pesticides in Cannabis and are there any that are the "main concerns" or ones that stand out as particularly damaging?
  • What is a basic breakdown of the testing and methods used for pesticide testing?
  • What are the best strategies for the sampling of cannabis products?

12:50 PM - Technology Spotlight

1:05 PM - Building a Lab in an Emerging Market
Chris Martinez, Co-Founder & President, EVIO Labs FL

  • Will present a discussion of the genesis of EVIO Labs Florida, how to start a lab in a new market
  • Challenges in how we navigated changing regulations in a state with newly legalized cannabis
  • Expanding a lab to a second location - logistics, hiring, training, consistency.

1:50 PM - Technology Spotlight 

2:05 PM - Cannabinoid & Terpene Testing: Methods, Strategies & Standardization
Dr. Cindy Orser, Chief Science Officer, Digipath Labs

  • Appreciation of "measurement uncertainty" in cannabis testing
  • Standardization of testing methods is a high priority
  • Terpenes are the distinguishing chemicals in cannabis sensory perception and chemotaxonomy

2:50 PM - Technology Spotlight

3:05 PM - Benefits of Accreditation to the ISO 17025:2017 Standard
Jane Weitzel, Independent Consultant

  • The ISO/IEC 17025:2017 standard is now being used to accredit cannabis testing laboratories. From this presentation you will learn the key new aspects of the standard. This includes risk-based thinking. Many aspects of this risk approach require the use of measurement uncertainty. This means the measurement uncertainty must be adequately evaluated. You will be introduced to evaluating and using measurement uncertainty.
  • The 2017 standard emphasizes conflict of interest and impartiality. Procedures and practices to achieve impartiality will be shown. This reduces the risk of potentially damaging leaks of information or the risk of people not working to the best interests of the laboratory and its clients.
  • The 2017 standard is a valuable and useful business tool that can save the laboratory resources, effort and money. Are you doing too much testing? Are you doing too little testing? When you evaluate the measurement uncertainty you can use it to learn the steps in your test method that need enhancement to reduce the risk of making mistakes. You can also use the measurement uncertainty to focus on the significant steps and stop wasting time on steps and activities that are insignificant.
  • These benefits of laboratory accreditation will be demonstrated with examples from the cannabis industry.

3:50 PM - Discussion

4:00 PM - Adjournment

SPEAKERS

Charles Deibel

Charles Deibel
President & CEO
Deibel Labs, Inc.

Charles Deibel is the President and CEO of Deibel Labs, Inc. an internationally recognized corporation of 15 testing labs in North America for over 50 years, serving the Food, Beverage, Personal Care, and Cannabis Industries.  As an industry advocate, Charles has testified before the House Energy and Commerce Committee on important food safety concerns. He worked with the Department of Justice to help shape the legal case against Peanut Corporation of America and testified as an expert witness during the trial.  As a microbiologist, Charles uses his industry experience and scientific knowledge to aid clients in Food Safety Plan development and recovering from bacterial remediation events.  Charles is a Certified HACCP Alliance Lead Instructor, a recognized Process Authority, a PCQI Lead Instructor, and performs cGMP / HACCP system development for clients of Deibel Labs.

Chris Martinez

Chris Martinez
Co-Founder & President
EVIO Labs Florida

Chris Martinez is the co-founder and president of EVIO Labs FL. He has enjoyed a 10-year long career as a surgical device consultant and entrepreneur. Christopher focused on training and educating physicians on the latest technologies and innovations available for orthopedic surgery. Mr. Martinez received his BS in Health Services Administration from Barry University where he graduated Magna Cum Laude.

Dr. Cindy Orser
Jane Weitzel

Dr. Cindy Orser
Chief Science Officer
Digipath Labs

Drawing from over 25 years of experience innovating in both academia and private industry, Dr. Orser holds twenty issued US Patents, numerous foreign patents and has authored forty-six peer-reviewed publications.  She was awarded a PhD from the University of California, Berkeley, where she discovered the molecular basis of bacterial ice nucleation to be a single genic trait.  She received her BS in Botany from Montana State University in Bozeman, and was also a tenured professor of Biochemistry and Bacteriology at the University of Idaho.

Ten years ago, Dr. Orser founded Big Sky Biosystems Inc.  In her role as Chief Scientific Advisor, she provides scientific, technical, regulatory, and strategic affairs consulting for the diagnostics and cannabis industry.  She also cofounded and served as CSO of ASDx Biosystems, Inc., a Boulder, Colorado company that developed and validated rapid diagnostic tests for Homeland Security in collaboration with the CDC to identify the biothreat agents ricin and botulinum toxins.   Prior to that for five years, Dr. Orser served as Corporate Senior Scientist and Head of the Biodefense/Biotechnology Initiative at Areté Associates, a DC physics-based company and leader in the design, integration and operation of in situ and remote sensing instrumentation where she invented an assay to measure protein-misfolding. Following that, she co-founded Adlyfe Inc., serving as the Director of R&D, where she was responsible for the management of all aspects of bringing to market an innovative blood diagnostic for misfolded proteins associated with prion-mediated neurodegenerative disease as well as a lyophilized human platelet product for thrombocytopenia, which was spun out into a new company, Cellphire Inc.

As CSO at DigiPath since 2014, Cindy has been creating a replicable cannabis testing environment with validated standard operating procedures to ensure cannabis and cannabis-based products are safe once they reach the dispensary shelves.  She is also promoting strain authentication through combining chemoprofile data analytics with strain genotyping to distinguish cannabis drug type strains currently being grown in the global cannabis market.

Jane Weitzel
Independent Consultant

 

Jane Weitzel has been working in analytical chemistry for over 40 years for pharmaceutical and mining companies.  She is currently a consultant specializing in laboratory management systems and ISO/IEC 17025, an auditor, and an educator. She works with the cannabis, food, environmental, mining, and pharmaceutical industries.

Jane has applied Quality Systems and statistical techniques, including the evaluation and use of measurement uncertainty, in a wide variety of technical and scientific businesses. She has obtained the American Society for Quality Certification for both Quality Engineer and Quality Manager. Jane is a lead assessor for a few accrediting bodies.

Jane is chair of the pharmaceutical sub-committee for AOAC Accreditation Guidelines for Laboratories (ALACC), the Guidelines for Laboratories Performing Microbiological and Chemical Analyses of Food, Dietary Supplements, and Pharmaceuticals – An Aid to the Interpretation of ISO/IEC 17025. Jane was appointed to the Chinese National Drug Reference Standards Committee and attended their inaugural meeting in Beijing. Jane is a member of the USP’s Expert Committee on Statistics and the Expert Panel on Method Validation and Verification For the 2015 – 2020 cycle.

Aaron Biros
Editor-in-Chief
CannabisIndustryJournal.com

Share This